NeuroSense Therapeutics Ltd. (NRSN) Revenue History
Annual and quarterly revenue from 2019 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NRSN Revenue Growth
NRSN Revenue Analysis (2019–2024)
As of May 8, 2026, NeuroSense Therapeutics Ltd. (NRSN) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q2 2025) recorded $0 in revenue.
Looking at the longer-term picture, NRSN's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including PRTA (-58.0% YoY), ACIU (-86.9% YoY), and IONS (+47.5% YoY). Compare NRSN vs PRTA →
NRSN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NRSNCurrent | $0 | - | - | - | |
 PRTA | $10M | -58.0% | +62.6% | -1905.8% | |
 ACIU | $4M | -86.9% | -25.4% | -1927.3% | |
 IONS | $944M | +47.5% | +5.3% | -40.5% |
NRSN Historical Revenue Data (2019–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-22,000 | - | $-9,902,000 | - |
| 2023 | $0 | - | $-97,000 | - | $-12,049,000 | - |
| 2022 | $0 | - | $-89,000 | - | $-13,552,000 | - |
| 2021 | $0 | - | $-3,000 | - | $-5,587,000 | - |
| 2020 | $0 | - | $-3,000 | - | $-2,888,000 | - |
| 2019 | $0 | - | $0 | - | $-1,235,000 | - |
See NRSN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NRSN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NRSN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNRSN — Frequently Asked Questions
Quick answers to the most common questions about buying NRSN stock.
Is NRSN's revenue growth accelerating or slowing?
NRSN TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is NRSN's long-term revenue growth rate?
NeuroSense Therapeutics Ltd.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is NRSN's revenue distributed by segment?
NRSN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2024 are available for download. Segment mix reveals concentration and diversification trends.